<?xml version='1.0' encoding='UTF-8'?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:video="http://www.google.com/schemas/sitemap-video/1.1" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"><url><loc>https://td2inc.com/news-events/td2-oncology-and-minerva-imaging-partner-to-expand-radiopharmaceutical-development-support</loc><image:image><image:loc>https://td2inc.com/hubfs/ASCO-2026.png</image:loc><image:caption>ASCO-2026</image:caption><image:title>ASCO-2026</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2026-07-22</lastmod></url><url><loc>https://td2inc.com/resources/antitumor-and-metabolomic-evaluation-of-immune-checkpoint-inhibition-in-diet-induced-obese-mice-stic-2023</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-abstract8.png</image:loc><image:caption>thumb-abstract8</image:caption><image:title>thumb-abstract8</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/resources/the-activation-profiling-of-stat-in-human-whole-blood-samples</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/flow-poster-2.png</image:loc><image:caption>flow-poster-2</image:caption><image:title>flow-poster-2</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/resources/design-and-validation-of-a-model-of-a-receptor-occupancy-assay</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/flow-poster-1.png</image:loc><image:caption>flow-poster-1</image:caption><image:title>flow-poster-1</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/news-events/td2-oncology-expands-flow-cytometry-expertise-to-advance-in-vivo-car-t-therapies-for-autoimmune-and-oncology-development</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2025-12-11</lastmod></url><url><loc>https://td2inc.com/resources/overcoming-oncology-clinical-trial-challenges</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-dr-alan-miller.jpeg</image:loc><image:caption>thumb-dr-alan-miller</image:caption><image:title>thumb-dr-alan-miller</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/preclinical-old</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/flow-thumb-4.png</image:loc><image:caption>flow-thumb-4</image:caption><image:title>flow-thumb-4</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-checkpoint-inhibitors.jpeg</image:loc><image:caption>thumb-checkpoint-inhibitors</image:caption><image:title>thumb-checkpoint-inhibitors</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/flow-thumb-8.png</image:loc><image:caption>flow-thumb-8</image:caption><image:title>flow-thumb-8</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/flow-poster-1.png</image:loc><image:caption>flow-poster-1</image:caption><image:title>flow-poster-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/ash-poster-thumb-2.png</image:loc><image:caption>ash-poster-thumb-2</image:caption><image:title>ash-poster-thumb-2</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/inhibition-of-hdac3.jpeg</image:loc><image:caption>inhibition-of-hdac3</image:caption><image:title>inhibition-of-hdac3</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/invitropharmacology.png</image:loc><image:caption>invitropharmacology</image:caption><image:title>invitropharmacology</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/invivopharmacology.png</image:loc><image:caption>invivopharmacology</image:caption><image:title>invivopharmacology</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/flow-thumb-9.png</image:loc><image:caption>flow-thumb-9</image:caption><image:title>flow-thumb-9</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/white-paper-optimizing-specimen-stability-thumb.png</image:loc><image:caption>white-paper-optimizing-specimen-stability-thumb</image:caption><image:title>white-paper-optimizing-specimen-stability-thumb</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-pk-adme2.png</image:loc><image:caption>icon-pk-adme2</image:caption><image:title>icon-pk-adme2</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-abstract8.png</image:loc><image:caption>thumb-abstract8</image:caption><image:title>thumb-abstract8</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-preclinical.jpg</image:loc><image:caption>og-preclinical</image:caption><image:title>og-preclinical</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/flow-thumb-6.png</image:loc><image:caption>flow-thumb-6</image:caption><image:title>flow-thumb-6</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/dio-for-io-studies.png</image:loc><image:caption>dio-for-io-studies</image:caption><image:title>dio-for-io-studies</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/pd-l1-graphic.png</image:loc><image:caption>pd-l1-graphic</image:caption><image:title>pd-l1-graphic</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/6491.png</image:loc><image:caption>6491</image:caption><image:title>6491</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/flow-wp-thumb.png</image:loc><image:caption>flow-wp-thumb</image:caption><image:title>flow-wp-thumb</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-lb343.jpeg</image:loc><image:caption>thumb-lb343</image:caption><image:title>thumb-lb343</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/510.png</image:loc><image:caption>510</image:caption><image:title>510</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/services-catalog-thumb.png</image:loc><image:caption>services-catalog-thumb</image:caption><image:title>services-catalog-thumb</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/global-metabolomics.png</image:loc><image:caption>global-metabolomics</image:caption><image:title>global-metabolomics</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/flow-poster-2.png</image:loc><image:caption>flow-poster-2</image:caption><image:title>flow-poster-2</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/thumb-poster-selective-hdac6-inhibition.jpg</image:loc><image:caption>thumb-poster-selective-hdac6-inhibition</image:caption><image:title>thumb-poster-selective-hdac6-inhibition</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/6908.png</image:loc><image:caption>6908</image:caption><image:title>6908</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/tumormodels.png</image:loc><image:caption>tumormodels</image:caption><image:title>tumormodels</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-the-dynamic-trial-design.jpeg</image:loc><image:caption>thumb-the-dynamic-trial-design</image:caption><image:title>thumb-the-dynamic-trial-design</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/flow-thumb-3.png</image:loc><image:caption>flow-thumb-3</image:caption><image:title>flow-thumb-3</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/systemic-metabolism.jpg</image:loc><image:caption>systemic-metabolism</image:caption><image:title>systemic-metabolism</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/past-phase-1.png</image:loc><image:caption>past-phase-1</image:caption><image:title>past-phase-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-pk-adme.jpg</image:loc><image:caption>og-pk-adme</image:caption><image:title>og-pk-adme</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/thumb-wp-exploring-the-effects-of-microbiome.jpg</image:loc><image:caption>thumb-wp-exploring-the-effects-of-microbiome</image:caption><image:title>thumb-wp-exploring-the-effects-of-microbiome</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/flow-poster-thumb.png</image:loc><image:caption>flow-poster-thumb</image:caption><image:title>flow-poster-thumb</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/thumb-poster-inhibition-of-hdac3.jpg</image:loc><image:caption>thumb-poster-inhibition-of-hdac3</image:caption><image:title>thumb-poster-inhibition-of-hdac3</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/selective-hdac6-inhibition.jpeg</image:loc><image:caption>selective-hdac6-inhibition</image:caption><image:title>selective-hdac6-inhibition</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/flow-thumb-5.png</image:loc><image:caption>flow-thumb-5</image:caption><image:title>flow-thumb-5</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/thumb-poc.png</image:loc><image:caption>thumb-poc</image:caption><image:title>thumb-poc</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-clinical-study-management.png</image:loc><image:caption>icon-clinical-study-management</image:caption><image:title>icon-clinical-study-management</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-webinar-clinical-success.png</image:loc><image:caption>thumb-webinar-clinical-success</image:caption><image:title>thumb-webinar-clinical-success</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-pk-adme-arrow-down-1.png</image:loc><image:caption>icon-pk-adme-arrow-down-1</image:caption><image:title>icon-pk-adme-arrow-down-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/1364-thumb.png</image:loc><image:caption>1364-thumb</image:caption><image:title>1364-thumb</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/report-thumb.jpeg</image:loc><image:caption>report-thumb</image:caption><image:title>report-thumb</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/flow-thumb-7.png</image:loc><image:caption>flow-thumb-7</image:caption><image:title>flow-thumb-7</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/vs-mice.png</image:loc><image:caption>vs-mice</image:caption><image:title>vs-mice</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thubm-ebook-cover.jpeg</image:loc><image:caption>thubm-ebook-cover</image:caption><image:title>thubm-ebook-cover</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Oncology-Ecosystem.jpeg</image:loc><image:caption>Oncology-Ecosystem</image:caption><image:title>Oncology-Ecosystem</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/podcast-thumb.png</image:loc><image:caption>podcast-thumb</image:caption><image:title>podcast-thumb</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/poster-measurement-of-basophil-activation.jpg</image:loc><image:caption>poster-measurement-of-basophil-activation</image:caption><image:title>poster-measurement-of-basophil-activation</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/iomodels.png</image:loc><image:caption>iomodels</image:caption><image:title>iomodels</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/6-signs.png</image:loc><image:caption>6-signs</image:caption><image:title>6-signs</image:title></image:image><lastmod>2025-04-01</lastmod></url><url><loc>https://td2inc.com/resources/streamlining-clinical-trial-start-ups</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/video-thumb-clinical-trial.png</image:loc><image:caption>video-thumb-clinical-trial</image:caption><image:title>video-thumb-clinical-trial</image:title></image:image><lastmod>2025-12-16</lastmod></url><url><loc>https://td2inc.com/news-events/atropos-evidence-network-grows-to-over-300-million-patients</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2024-06-24</lastmod></url><url><loc>https://td2inc.com/news-events/dr-daniel-d-von-hoff-named-one-of-ascos-50-oncology-luminaries</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/news-events/merrimack-and-td2-work-together-on-the-phase-1-study-of-mm-310</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/news-events/td2-oncology-and-panome-bio-partner-to-advance-translational-oncology-through-integrated-multi-omics-capabilities</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2026-05-27</lastmod></url><url><loc>https://td2inc.com/news-events/td2-helps-sideout-foundation-with-the-conduct-of-their-trial</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/news-events/forma-therapeutics-teams-with-td2</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2024-04-01</lastmod></url><url><loc>https://td2inc.com/terms-and-conditions</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-home.jpg</image:loc><image:caption>og-home</image:caption><image:title>og-home</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2024-04-04</lastmod></url><url><loc>https://td2inc.com/cancer-vaccine-development</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-pk-adme2.png</image:loc><image:caption>icon-pk-adme2</image:caption><image:title>icon-pk-adme2</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-clinical-study-management.png</image:loc><image:caption>icon-clinical-study-management</image:caption><image:title>icon-clinical-study-management</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/small-molecules.png</image:loc><image:caption>small-molecules</image:caption><image:title>small-molecules</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-pk-adme-arrow-down-1.png</image:loc><image:caption>icon-pk-adme-arrow-down-1</image:caption><image:title>icon-pk-adme-arrow-down-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/cancer-vaccine-development.png</image:loc><image:caption>cancer-vaccine-development</image:caption><image:title>cancer-vaccine-development</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2025-06-18</lastmod></url><url><loc>https://td2inc.com/news-events/forma-therapeutics-announces-advancement-of-tumor-metabolism-collaboration-with-janssen</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/news-events/targeted-radiopharmaceuticals-summit-us</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2026-02-19</lastmod></url><url><loc>https://td2inc.com/contact-us</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-phone.png</image:loc><image:caption>icon-phone</image:caption><image:title>icon-phone</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/icon-person.png</image:loc><image:caption>icon-person</image:caption><image:title>icon-person</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-location.png</image:loc><image:caption>icon-location</image:caption><image:title>icon-location</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-contact.jpg</image:loc><image:caption>og-contact</image:caption><image:title>og-contact</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/contact-image1.png</image:loc><image:caption>contact-image1</image:caption><image:title>contact-image1</image:title></image:image><lastmod>2025-08-29</lastmod></url><url><loc>https://td2inc.com/resources/epigenetic-based-combinatorial-therapy-is-synergistic</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/6491.png</image:loc><image:caption>6491</image:caption><image:title>6491</image:title></image:image><lastmod>2024-06-16</lastmod></url><url><loc>https://td2inc.com/resources/poster-measurement-of-basophil-activation-using-a-flow-cytometry-method</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/poster-measurement-of-basophil-activation.jpg</image:loc><image:caption>poster-measurement-of-basophil-activation</image:caption><image:title>poster-measurement-of-basophil-activation</image:title></image:image><lastmod>2025-04-26</lastmod></url><url><loc>https://td2inc.com/resources/10-color-flow-cytometry-panels-for-the-evaluation-of-t-cell-subsets</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/flow-thumb-4.png</image:loc><image:caption>flow-thumb-4</image:caption><image:title>flow-thumb-4</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/resources/comprehensive-oncology-ecosystem</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Oncology-Ecosystem.jpeg</image:loc><image:caption>Oncology-Ecosystem</image:caption><image:title>Oncology-Ecosystem</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2024-11-06</lastmod></url><url><loc>https://td2inc.com/regulatory-support</loc><image:image><image:loc>https://td2inc.com/hubfs/icon-Program-Budget-&amp;-Timeline-Executive-Plan.png</image:loc><image:caption>icon-Program-Budget-&amp;-Timeline-Executive-Plan</image:caption><image:title>icon-Program-Budget-&amp;-Timeline-Executive-Plan</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/icon-Expert-Panel-Discussions.png</image:loc><image:caption>icon-Expert-Panel-Discussions</image:caption><image:title>icon-Expert-Panel-Discussions</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/mountain-bg-purple.png</image:loc><image:caption>mountain-bg-purple</image:caption><image:title>mountain-bg-purple</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/oncology-ecosystem.jpg</image:loc><image:caption>oncology-ecosystem</image:caption><image:title>oncology-ecosystem</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Oncology-Ecosystem.jpeg</image:loc><image:caption>Oncology-Ecosystem</image:caption><image:title>Oncology-Ecosystem</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/icon-Full-Program-Management-&amp;-Regulatory-Consulting.png</image:loc><image:caption>icon-Full-Program-Management-&amp;-Regulatory-Consulting</image:caption><image:title>icon-Full-Program-Management-&amp;-Regulatory-Consulting</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/video-thumb-clinical-trial.png</image:loc><image:caption>video-thumb-clinical-trial</image:caption><image:title>video-thumb-clinical-trial</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/shutterstock_267243104.jpg</image:loc><image:caption>shutterstock_267243104</image:caption><image:title>shutterstock_267243104</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/icon-Protocol-Design.png</image:loc><image:caption>icon-Protocol-Design</image:caption><image:title>icon-Protocol-Design</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-regulatory-process-ebook.png</image:loc><image:caption>thumb-regulatory-process-ebook</image:caption><image:title>thumb-regulatory-process-ebook</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/icon-Gap-Analysis-&amp;-Regulatory-Consulting.png</image:loc><image:caption>icon-Gap-Analysis-&amp;-Regulatory-Consulting</image:caption><image:title>icon-Gap-Analysis-&amp;-Regulatory-Consulting</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-webinar-clinical-success.png</image:loc><image:caption>thumb-webinar-clinical-success</image:caption><image:title>thumb-webinar-clinical-success</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/icon-Regulatory%2c-Scientific-&amp;-Medical-Writing.png</image:loc><image:caption>icon-Regulatory,-Scientific-&amp;-Medical-Writing</image:caption><image:title>icon-Regulatory,-Scientific-&amp;-Medical-Writing</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Tailored-Regulatory-Solutions-img.png</image:loc><image:caption>Tailored-Regulatory-Solutions-img</image:caption><image:title>Tailored-Regulatory-Solutions-img</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/icon-Trial-Enabling-Program.png</image:loc><image:caption>icon-Trial-Enabling-Program</image:caption><image:title>icon-Trial-Enabling-Program</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/regulatory-bg.jpg</image:loc><image:caption>regulatory-bg</image:caption><image:title>regulatory-bg</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Accelerating-Clinical-Start-Up.png</image:loc><image:caption>Accelerating-Clinical-Start-Up</image:caption><image:title>Accelerating-Clinical-Start-Up</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/icon-Submission-and-Specialty-Filing.png</image:loc><image:caption>icon-Submission-and-Specialty-Filing</image:caption><image:title>icon-Submission-and-Specialty-Filing</image:title></image:image><lastmod>2025-04-09</lastmod></url><url><loc>https://td2inc.com/leadership-team</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Avatar/tara-franks.jpg</image:loc><image:caption>tara-franks</image:caption><image:title>tara-franks</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Avatar/shaun-kirkpatrick.jpg</image:loc><image:caption>shaun-kirkpatrick</image:caption><image:title>shaun-kirkpatrick</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/miller.png</image:loc><image:caption>miller</image:caption><image:title>miller</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Avatar/daniel-von-hoff.jpg</image:loc><image:caption>daniel-von-hoff</image:caption><image:title>daniel-von-hoff</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Avatar/matthew-witman.jpg</image:loc><image:caption>matthew-witman</image:caption><image:title>matthew-witman</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Avatar/susan-tessmann.jpg</image:loc><image:caption>susan-tessmann</image:caption><image:title>susan-tessmann</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Avatar/chad-souvignier.jpg</image:loc><image:caption>chad-souvignier</image:caption><image:title>chad-souvignier</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Avatar/jenny-keppler.jpg</image:loc><image:caption>jenny-keppler</image:caption><image:title>jenny-keppler</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Avatar/shawnna-rustenbeck.jpg</image:loc><image:caption>shawnna-rustenbeck</image:caption><image:title>shawnna-rustenbeck</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-image-1.jpg</image:loc><image:caption>og-image-1</image:caption><image:title>og-image-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/donovan-3.png</image:loc><image:caption>donovan-3</image:caption><image:title>donovan-3</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/chris.png</image:loc><image:caption>chris</image:caption><image:title>chris</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/stephen-gately.png</image:loc><image:caption>stephen-gately</image:caption><image:title>stephen-gately</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Avatar/marc-appelbaum.jpg</image:loc><image:caption>marc-appelbaum</image:caption><image:title>marc-appelbaum</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/ashley-hunter.png</image:loc><image:caption>ashley-hunter</image:caption><image:title>ashley-hunter</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Avatar/eric-tooker.jpg</image:loc><image:caption>eric-tooker</image:caption><image:title>eric-tooker</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Avatar/paul-gonzales.jpg</image:loc><image:caption>paul-gonzales</image:caption><image:title>paul-gonzales</image:title></image:image><lastmod>2026-02-23</lastmod></url><url><loc>https://td2inc.com/resources/advanced-adc-evaluation-at-td2</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-td2-adc.jpg</image:loc><image:caption>thumb-td2-adc</image:caption><image:title>thumb-td2-adc</image:title></image:image><lastmod>2024-06-27</lastmod></url><url><loc>https://td2inc.com/resources/the-a-z-guide-of-dmpk-assays-and-how-to-find-the-right-one</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/how-to-find-the-right-dmpk-assay-mix-02.png</image:loc><image:caption>how-to-find-the-right-dmpk-assay-mix-02</image:caption><image:title>how-to-find-the-right-dmpk-assay-mix-02</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2024-06-16</lastmod></url><url><loc>https://td2inc.com/resources/the-advantages-of-fluorescent-barcoding-of-human-cells</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/flow-thumb-3.png</image:loc><image:caption>flow-thumb-3</image:caption><image:title>flow-thumb-3</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/etmf-management-services</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-clinical-study-management.png</image:loc><image:caption>icon-clinical-study-management</image:caption><image:title>icon-clinical-study-management</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-clinical-study-management.jpg</image:loc><image:caption>og-clinical-study-management</image:caption><image:title>og-clinical-study-management</image:title></image:image><lastmod>2025-06-18</lastmod></url><url><loc>https://td2inc.com/resources</loc><image:image><image:loc>https://td2inc.com/hubfs/mountain.jpg</image:loc><image:caption>mountain</image:caption><image:title>mountain</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-td2-clinical-capabilities.jpeg</image:loc><image:caption>thumb-td2-clinical-capabilities</image:caption><image:title>thumb-td2-clinical-capabilities</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/poster-thumb-1273.jpg</image:loc><image:caption>poster-thumb-1273</image:caption><image:title>poster-thumb-1273</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/1364-thumb.png</image:loc><image:caption>1364-thumb</image:caption><image:title>1364-thumb</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/6908.png</image:loc><image:caption>6908</image:caption><image:title>6908</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/receptor-mediated-webinar.png</image:loc><image:caption>receptor-mediated-webinar</image:caption><image:title>receptor-mediated-webinar</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-glioblastoma-capabilities.jpeg</image:loc><image:caption>thumb-glioblastoma-capabilities</image:caption><image:title>thumb-glioblastoma-capabilities</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/cancer-trial-recruitment.png</image:loc><image:caption>cancer-trial-recruitment</image:caption><image:title>cancer-trial-recruitment</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/white-paper-optimizing-specimen-stability-thumb.png</image:loc><image:caption>white-paper-optimizing-specimen-stability-thumb</image:caption><image:title>white-paper-optimizing-specimen-stability-thumb</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-pk-adme.jpg</image:loc><image:caption>og-pk-adme</image:caption><image:title>og-pk-adme</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-blog-key-considerations.jpeg</image:loc><image:caption>thumb-blog-key-considerations</image:caption><image:title>thumb-blog-key-considerations</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Oncology-Ecosystem.jpeg</image:loc><image:caption>Oncology-Ecosystem</image:caption><image:title>Oncology-Ecosystem</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/flow-poster-thumb.png</image:loc><image:caption>flow-poster-thumb</image:caption><image:title>flow-poster-thumb</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-td2-adc.jpg</image:loc><image:caption>thumb-td2-adc</image:caption><image:title>thumb-td2-adc</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/poster-measurement-of-basophil-activation.jpg</image:loc><image:caption>poster-measurement-of-basophil-activation</image:caption><image:title>poster-measurement-of-basophil-activation</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/kpis.png</image:loc><image:caption>kpis</image:caption><image:title>kpis</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/next-generation-oncology-trials.jpg</image:loc><image:caption>next-generation-oncology-trials</image:caption><image:title>next-generation-oncology-trials</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/how-to-find-the-right-dmpk-assay-mix-02.png</image:loc><image:caption>how-to-find-the-right-dmpk-assay-mix-02</image:caption><image:title>how-to-find-the-right-dmpk-assay-mix-02</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/video-thumb-stephen-gately.png</image:loc><image:caption>video-thumb-stephen-gately</image:caption><image:title>video-thumb-stephen-gately</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Webinar%20Hero%20Image.png</image:loc><image:caption>Webinar Hero Image</image:caption><image:title>Webinar Hero Image</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-td2-immuno-oncology.jpeg</image:loc><image:caption>thumb-td2-immuno-oncology</image:caption><image:title>thumb-td2-immuno-oncology</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/systemic-metabolism.jpg</image:loc><image:caption>systemic-metabolism</image:caption><image:title>systemic-metabolism</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/inhibition-of-hdac3.jpeg</image:loc><image:caption>inhibition-of-hdac3</image:caption><image:title>inhibition-of-hdac3</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/flow-thumb-3.png</image:loc><image:caption>flow-thumb-3</image:caption><image:title>flow-thumb-3</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/510.png</image:loc><image:caption>510</image:caption><image:title>510</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/thumb-poc.png</image:loc><image:caption>thumb-poc</image:caption><image:title>thumb-poc</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-partner-with-experienced.jpeg</image:loc><image:caption>thumb-partner-with-experienced</image:caption><image:title>thumb-partner-with-experienced</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/6491.png</image:loc><image:caption>6491</image:caption><image:title>6491</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/shutterstock_267243104.jpg</image:loc><image:caption>shutterstock_267243104</image:caption><image:title>shutterstock_267243104</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/flow-thumb-5.png</image:loc><image:caption>flow-thumb-5</image:caption><image:title>flow-thumb-5</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/report-thumb.jpeg</image:loc><image:caption>report-thumb</image:caption><image:title>report-thumb</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/flow-poster-2.png</image:loc><image:caption>flow-poster-2</image:caption><image:title>flow-poster-2</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-abstract8.png</image:loc><image:caption>thumb-abstract8</image:caption><image:title>thumb-abstract8</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-lisa-burke.jpeg</image:loc><image:caption>thumb-lisa-burke</image:caption><image:title>thumb-lisa-burke</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/flow-wp-thumb.png</image:loc><image:caption>flow-wp-thumb</image:caption><image:title>flow-wp-thumb</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-checkpoint-inhibitors.jpeg</image:loc><image:caption>thumb-checkpoint-inhibitors</image:caption><image:title>thumb-checkpoint-inhibitors</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/wp-thumb-early-phase.png</image:loc><image:caption>wp-thumb-early-phase</image:caption><image:title>wp-thumb-early-phase</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/car-t-blog.jpeg</image:loc><image:caption>car-t-blog</image:caption><image:title>car-t-blog</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/flow-poster-1.png</image:loc><image:caption>flow-poster-1</image:caption><image:title>flow-poster-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/flow-thumb-8.png</image:loc><image:caption>flow-thumb-8</image:caption><image:title>flow-thumb-8</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/quick-start-guide.png</image:loc><image:caption>quick-start-guide</image:caption><image:title>quick-start-guide</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/past-phase-1.png</image:loc><image:caption>past-phase-1</image:caption><image:title>past-phase-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/pd-l1-graphic.png</image:loc><image:caption>pd-l1-graphic</image:caption><image:title>pd-l1-graphic</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/project-optimus-thumb.jpg</image:loc><image:caption>project-optimus-thumb</image:caption><image:title>project-optimus-thumb</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/efficient-data-management.png</image:loc><image:caption>efficient-data-management</image:caption><image:title>efficient-data-management</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/flow-thumb-4.png</image:loc><image:caption>flow-thumb-4</image:caption><image:title>flow-thumb-4</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-resources.jpg</image:loc><image:caption>og-resources</image:caption><image:title>og-resources</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/flow-thumb-9.png</image:loc><image:caption>flow-thumb-9</image:caption><image:title>flow-thumb-9</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/flow-thumb-6.png</image:loc><image:caption>flow-thumb-6</image:caption><image:title>flow-thumb-6</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-lb343.jpeg</image:loc><image:caption>thumb-lb343</image:caption><image:title>thumb-lb343</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/services-catalog-thumb.png</image:loc><image:caption>services-catalog-thumb</image:caption><image:title>services-catalog-thumb</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-dr-alan-miller.jpeg</image:loc><image:caption>thumb-dr-alan-miller</image:caption><image:title>thumb-dr-alan-miller</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thubm-ebook-cover.jpeg</image:loc><image:caption>thubm-ebook-cover</image:caption><image:title>thubm-ebook-cover</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/dynamic-trial.png</image:loc><image:caption>dynamic-trial</image:caption><image:title>dynamic-trial</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/video-thumb-clinical-trial.png</image:loc><image:caption>video-thumb-clinical-trial</image:caption><image:title>video-thumb-clinical-trial</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/dio-for-io-studies.png</image:loc><image:caption>dio-for-io-studies</image:caption><image:title>dio-for-io-studies</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/thumb-poster-selective-hdac6-inhibition.jpg</image:loc><image:caption>thumb-poster-selective-hdac6-inhibition</image:caption><image:title>thumb-poster-selective-hdac6-inhibition</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-podcast-biomarkers-and-the-utility-of-proteomics.jpeg</image:loc><image:caption>thumb-podcast-biomarkers-and-the-utility-of-proteomics</image:caption><image:title>thumb-podcast-biomarkers-and-the-utility-of-proteomics</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-susan-tessman.jpeg</image:loc><image:caption>thumb-susan-tessman</image:caption><image:title>thumb-susan-tessman</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/data-insights.png</image:loc><image:caption>data-insights</image:caption><image:title>data-insights</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/ash-poster-thumb-2.png</image:loc><image:caption>ash-poster-thumb-2</image:caption><image:title>ash-poster-thumb-2</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/podcast-thumb.png</image:loc><image:caption>podcast-thumb</image:caption><image:title>podcast-thumb</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/successful-cancer-treatments-trends.png</image:loc><image:caption>successful-cancer-treatments-trends</image:caption><image:title>successful-cancer-treatments-trends</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-executive-interview-with-td2.jpeg</image:loc><image:caption>thumb-executive-interview-with-td2</image:caption><image:title>thumb-executive-interview-with-td2</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/deep-dive-cro-landscape.png</image:loc><image:caption>deep-dive-cro-landscape</image:caption><image:title>deep-dive-cro-landscape</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/thumb-wp-exploring-the-effects-of-microbiome.jpg</image:loc><image:caption>thumb-wp-exploring-the-effects-of-microbiome</image:caption><image:title>thumb-wp-exploring-the-effects-of-microbiome</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/poster-219-thumb-2.jpg</image:loc><image:caption>poster-219-thumb-2</image:caption><image:title>poster-219-thumb-2</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/res-video-cell-therapy-at-td2-thumb-1.jpeg</image:loc><image:caption>res-video-cell-therapy-at-td2-thumb-1</image:caption><image:title>res-video-cell-therapy-at-td2-thumb-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-webinar-clinical-success.png</image:loc><image:caption>thumb-webinar-clinical-success</image:caption><image:title>thumb-webinar-clinical-success</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-regulatory-process-ebook.png</image:loc><image:caption>thumb-regulatory-process-ebook</image:caption><image:title>thumb-regulatory-process-ebook</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-tech-slam.jpeg</image:loc><image:caption>thumb-tech-slam</image:caption><image:title>thumb-tech-slam</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/poster-6908-1.png</image:loc><image:caption>poster-6908-1</image:caption><image:title>poster-6908-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/selective-hdac6-inhibition.jpeg</image:loc><image:caption>selective-hdac6-inhibition</image:caption><image:title>selective-hdac6-inhibition</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-the-dynamic-trial-design.jpeg</image:loc><image:caption>thumb-the-dynamic-trial-design</image:caption><image:title>thumb-the-dynamic-trial-design</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/6-signs.png</image:loc><image:caption>6-signs</image:caption><image:title>6-signs</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/thumb-poster-inhibition-of-hdac3.jpg</image:loc><image:caption>thumb-poster-inhibition-of-hdac3</image:caption><image:title>thumb-poster-inhibition-of-hdac3</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-clinical-trial-highlight.jpeg</image:loc><image:caption>thumb-clinical-trial-highlight</image:caption><image:title>thumb-clinical-trial-highlight</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/flow-thumb-7.png</image:loc><image:caption>flow-thumb-7</image:caption><image:title>flow-thumb-7</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/vs-mice.png</image:loc><image:caption>vs-mice</image:caption><image:title>vs-mice</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/global-metabolomics.png</image:loc><image:caption>global-metabolomics</image:caption><image:title>global-metabolomics</image:title></image:image><lastmod>2024-10-27</lastmod></url><url><loc>https://td2inc.com/news-events/td2-and-viecure-partner-to-bring-best-in-class-cancer-medicines-and-access-to-precision-oncology-clinical-trials-to-patients-in-community-oncology-practices</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/news-events/outsourcing-pharma-targeting-special-patient-populations-with-the-help-of-ai</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/resources/how-td2-is-strengthening-site-collaboration-through-data-and-shared-kpis</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/kpis.png</image:loc><image:caption>kpis</image:caption><image:title>kpis</image:title></image:image><lastmod>2026-03-26</lastmod></url><url><loc>https://td2inc.com/resources/inhibition-of-hdac3</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/thumb-poster-inhibition-of-hdac3.jpg</image:loc><image:caption>thumb-poster-inhibition-of-hdac3</image:caption><image:title>thumb-poster-inhibition-of-hdac3</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/resources/development-of-a-receptor-occupancy-assay-for-a-therapeutic-bi-specific-antibody</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/poster-219-thumb-2.jpg</image:loc><image:caption>poster-219-thumb-2</image:caption><image:title>poster-219-thumb-2</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2026-02-10</lastmod></url><url><loc>https://td2inc.com/otis-council</loc><image:image><image:loc>https://td2inc.com/hubfs/radiopharmaceuticals.jpg</image:loc><image:caption>radiopharmaceuticals</image:caption><image:title>radiopharmaceuticals</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/theranostics.png</image:loc><image:caption>theranostics</image:caption><image:title>theranostics</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/radiopharmaceutical-development.jpg</image:loc><image:caption>radiopharmaceutical-development</image:caption><image:title>radiopharmaceutical-development</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Webinar%20Hero%20Image.png</image:loc><image:caption>Webinar Hero Image</image:caption><image:title>Webinar Hero Image</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/otis-banner.png</image:loc><image:caption>otis-banner</image:caption><image:title>otis-banner</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-pk-adme2.png</image:loc><image:caption>icon-pk-adme2</image:caption><image:title>icon-pk-adme2</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/radiopharma-fda.jpg</image:loc><image:caption>radiopharma-fda</image:caption><image:title>radiopharma-fda</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-pk-adme-arrow-down-1.png</image:loc><image:caption>icon-pk-adme-arrow-down-1</image:caption><image:title>icon-pk-adme-arrow-down-1</image:title></image:image><lastmod>2025-12-09</lastmod></url><url><loc>https://td2inc.com/news-events/phoenix-titan-100-award</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/titan-100.png</image:loc><image:caption>titan-100</image:caption><image:title>titan-100</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2024-07-03</lastmod></url><url><loc>https://td2inc.com/resources/the-vital-role-of-highly-characterized-glioblastoma-pdx-models-in-preclinical-cancer-research-insights-from-td2s-most-recent-studies</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/poster-6908-1.png</image:loc><image:caption>poster-6908-1</image:caption><image:title>poster-6908-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2024-06-16</lastmod></url><url><loc>https://td2inc.com/resources/efficient-data-management-one-way-to-expedite-the-clinical-development-process</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/efficient-data-management.png</image:loc><image:caption>efficient-data-management</image:caption><image:title>efficient-data-management</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/navigating-the-ind-process-with-confidence</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/checklist-thumb.png</image:loc><image:caption>checklist-thumb</image:caption><image:title>checklist-thumb</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/IND-Process.jpg</image:loc><image:caption>IND-Process</image:caption><image:title>IND-Process</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/shutterstock_267243104.jpg</image:loc><image:caption>shutterstock_267243104</image:caption><image:title>shutterstock_267243104</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2025-02-27</lastmod></url><url><loc>https://td2inc.com/resources/data-insights-identifying-early-signs-of-safety-and-efficacy-in-oncology-clinical-trials</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/data-insights.png</image:loc><image:caption>data-insights</image:caption><image:title>data-insights</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/news-events/td2-to-present-at-the-upcoming-4th-annual-tumor-models-in-bosto</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/vivarium-monitoring-report</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-pk-adme.jpg</image:loc><image:caption>og-pk-adme</image:caption><image:title>og-pk-adme</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2024-03-17</lastmod></url><url><loc>https://td2inc.com/news-events/what-is-the-difference-between-standard-therapy-and-experimental-therapy-in-a-cancer-clinical-trial</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/resources/validated-tumor-cell-lines</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/thumb-poc.png</image:loc><image:caption>thumb-poc</image:caption><image:title>thumb-poc</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2024-06-16</lastmod></url><url><loc>https://td2inc.com/resources/tech-slam</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-tech-slam.jpeg</image:loc><image:caption>thumb-tech-slam</image:caption><image:title>thumb-tech-slam</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/pharmacovigilance</loc><image:image><image:loc>https://td2inc.com/hubfs/safety-oversight-1.png</image:loc><image:caption>safety-oversight-1</image:caption><image:title>safety-oversight-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-clinical-study-management.png</image:loc><image:caption>icon-clinical-study-management</image:caption><image:title>icon-clinical-study-management</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-clinical-study-management.jpg</image:loc><image:caption>og-clinical-study-management</image:caption><image:title>og-clinical-study-management</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2025-06-18</lastmod></url><url><loc>https://td2inc.com/resources/biomarkers-and-the-utility-of-proteomics</loc><image:image><image:loc>https://td2inc.com/hubfs/thumb-podcast-biomarkers-and-the-utility-of-proteomics.jpeg</image:loc><image:caption>thumb-podcast-biomarkers-and-the-utility-of-proteomics</image:caption><image:title>thumb-podcast-biomarkers-and-the-utility-of-proteomics</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/news-events/are-all-investigational-drugs-available-through-an-expanded-access-or-special-exemption-mechanism</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/resources/integrating-pdx-gbm-in-vivo-models-with-patient-history-and-whole-exome-sequencing</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/6908.png</image:loc><image:caption>6908</image:caption><image:title>6908</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2024-06-16</lastmod></url><url><loc>https://td2inc.com/news-events/qualigen-therapeutics-engages-td2-as-contract-research-organization-for-preclinical-development-of-qn-302</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/news-events/ready-to-make-an-impact-join-our-team</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/resources/webinar-the-future-of-advanced-receptor-mediated-therapies</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/receptor-mediated-webinar.png</image:loc><image:caption>receptor-mediated-webinar</image:caption><image:title>receptor-mediated-webinar</image:title></image:image><lastmod>2025-12-16</lastmod></url><url><loc>https://td2inc.com/news-events/td2-business-continuity-during-covid-19</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/news-events/fda-approves-drug-tested-by-scottsdale-healthcare-and-tgen</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/resources/the-dynamic-trial-is-it-the-right-option-for-you</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/dynamic-trial.png</image:loc><image:caption>dynamic-trial</image:caption><image:title>dynamic-trial</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/resources/advancing-antibody-drug-conjugate-therapies</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-webinar-clinical-success.png</image:loc><image:caption>thumb-webinar-clinical-success</image:caption><image:title>thumb-webinar-clinical-success</image:title></image:image><lastmod>2024-11-05</lastmod></url><url><loc>https://td2inc.com/resources/improving-oncology-clinical-trial-success</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-lisa-burke.jpeg</image:loc><image:caption>thumb-lisa-burke</image:caption><image:title>thumb-lisa-burke</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/resources/flow-cytometry-based-assessment-of-innate-immune-function</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/flow-thumb-6.png</image:loc><image:caption>flow-thumb-6</image:caption><image:title>flow-thumb-6</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/clinical-trial-services-for-radiopharmaceuticals</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/radiopharmaceuticals.jpg</image:loc><image:caption>radiopharmaceuticals</image:caption><image:title>radiopharmaceuticals</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/radiopharma-fda.jpg</image:loc><image:caption>radiopharma-fda</image:caption><image:title>radiopharma-fda</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-clinical-study-management.png</image:loc><image:caption>icon-clinical-study-management</image:caption><image:title>icon-clinical-study-management</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-pk-adme2.png</image:loc><image:caption>icon-pk-adme2</image:caption><image:title>icon-pk-adme2</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-pk-adme-arrow-down-1.png</image:loc><image:caption>icon-pk-adme-arrow-down-1</image:caption><image:title>icon-pk-adme-arrow-down-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/radiopharmaceutical-development.jpg</image:loc><image:caption>radiopharmaceutical-development</image:caption><image:title>radiopharmaceutical-development</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Webinar%20Hero%20Image.png</image:loc><image:caption>Webinar Hero Image</image:caption><image:title>Webinar Hero Image</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/theranostics.png</image:loc><image:caption>theranostics</image:caption><image:title>theranostics</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/radiopharmaceutical-clinical-trials-charts-1.png</image:loc><image:caption>radiopharmaceutical-clinical-trials-charts-1</image:caption><image:title>radiopharmaceutical-clinical-trials-charts-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/pharmaceuticals.jpg</image:loc><image:caption>pharmaceuticals</image:caption><image:title>pharmaceuticals</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/jenny-thumb.jpg</image:loc><image:caption>jenny-thumb</image:caption><image:title>jenny-thumb</image:title></image:image><lastmod>2026-03-04</lastmod></url><url><loc>https://td2inc.com</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/fih-webinar-2.png</image:loc><image:caption>fih-webinar-2</image:caption><image:title>fih-webinar-2</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/keto-pr.png</image:loc><image:caption>keto-pr</image:caption><image:title>keto-pr</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/icon-pill-bottle.png</image:loc><image:caption>icon-pill-bottle</image:caption><image:title>icon-pill-bottle</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/press-flow.png</image:loc><image:caption>press-flow</image:caption><image:title>press-flow</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/icon-mouse-3.png</image:loc><image:caption>icon-mouse-3</image:caption><image:title>icon-mouse-3</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/icon-clipboard.png</image:loc><image:caption>icon-clipboard</image:caption><image:title>icon-clipboard</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/podcast.png</image:loc><image:caption>podcast</image:caption><image:title>podcast</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/home-section-bg.png</image:loc><image:caption>home-section-bg</image:caption><image:title>home-section-bg</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/hero-banner.png</image:loc><image:caption>hero-banner</image:caption><image:title>hero-banner</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/TD2-Panome-Announcement.png</image:loc><image:caption>TD2-Panome-Announcement</image:caption><image:title>TD2-Panome-Announcement</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/ASCO-2026.png</image:loc><image:caption>ASCO-2026</image:caption><image:title>ASCO-2026</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-pk-adme2.png</image:loc><image:caption>icon-pk-adme2</image:caption><image:title>icon-pk-adme2</image:title></image:image><lastmod>2026-07-22</lastmod></url><url><loc>https://td2inc.com/resources/poster-advancing-precision-oncology</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/poster-thumb-1273.jpg</image:loc><image:caption>poster-thumb-1273</image:caption><image:title>poster-thumb-1273</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2025-04-26</lastmod></url><url><loc>https://td2inc.com/news-events/td2-to-present-precision-preclinical-applications-for-glioblastoma-and-non-small-cell-lung-cancer-at-aacr-annual-meeting</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2024-06-16</lastmod></url><url><loc>https://td2inc.com/resources/cell-therapy-at-td2</loc><image:image><image:loc>https://td2inc.com/hubfs/res-video-cell-therapy-at-td2-thumb-1.jpeg</image:loc><image:caption>res-video-cell-therapy-at-td2-thumb-1</image:caption><image:title>res-video-cell-therapy-at-td2-thumb-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/news-events/forma-therapeutics-makes-deal-with-celgene-potentially-worth-600m</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/news-events/merrimack-and-td2-work-together-on-the-phase-1-study-of-mm-310-0</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/news-events/pancreatic-cancer-research-team-pcrt-celebrates-its-10-year-anniversary-of-delivering-new-treatments-for-patients-with-pancreatic-cancer</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/resources/car-t-cell-program-development-key-considerations</loc><image:image><image:loc>https://td2inc.com/hubfs/thumb-blog-key-considerations.jpeg</image:loc><image:caption>thumb-blog-key-considerations</image:caption><image:title>thumb-blog-key-considerations</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/resources/immunophenotyping-pig-immune-cells-by-flow-cytometry</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/flow-thumb-9.png</image:loc><image:caption>flow-thumb-9</image:caption><image:title>flow-thumb-9</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/resources/exploring-project-optimus-with-td2</loc><image:image><image:loc>https://td2inc.com/hubfs/project-optimus-thumb.jpg</image:loc><image:caption>project-optimus-thumb</image:caption><image:title>project-optimus-thumb</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2024-08-05</lastmod></url><url><loc>https://td2inc.com/news-events/stephen-gately-discusses-precision-medicine-in-applied-clinical-trials</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/news-events/responsibility-for-pancreatic-cancer-research-team-moves-to-seattle-non-profit-institution</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/news-events/enzada-pharmaceuticals-opens-phase-1b-metastatic-breast-cancer-trial</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/strategic-third-party-vendor-management</loc><image:image><image:loc>https://td2inc.com/hubfs/circles-graphic-1.png</image:loc><image:caption>circles-graphic-1</image:caption><image:title>circles-graphic-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-clinical-study-management.png</image:loc><image:caption>icon-clinical-study-management</image:caption><image:title>icon-clinical-study-management</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-clinical-study-management.jpg</image:loc><image:caption>og-clinical-study-management</image:caption><image:title>og-clinical-study-management</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2025-06-18</lastmod></url><url><loc>https://td2inc.com/resources/design-and-validation-of-a-model-of-a-receptor-occupancy-assay-for-a-new-immunotherapy-in-human-whole-blood-specimens</loc><image:image><image:loc>https://td2inc.com/hubfs/flow-poster-thumb.png</image:loc><image:caption>flow-poster-thumb</image:caption><image:title>flow-poster-thumb</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2024-11-19</lastmod></url><url><loc>https://td2inc.com/news-events/biospace-what-does-2020-have-in-store-for-life-sciences</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/resources/glioblastoma-capabilities</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-glioblastoma-capabilities.jpeg</image:loc><image:caption>thumb-glioblastoma-capabilities</image:caption><image:title>thumb-glioblastoma-capabilities</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/resources/exploring-the-effects-of-microbiome-in-precision-oncology-therapeutic-development</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/thumb-wp-exploring-the-effects-of-microbiome.jpg</image:loc><image:caption>thumb-wp-exploring-the-effects-of-microbiome</image:caption><image:title>thumb-wp-exploring-the-effects-of-microbiome</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/news-events/tgen-drug-development-td2-partnership-with-imaging-endpoints-provides-comprehensive-clinical-trial-services-for-drug-developers</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><lastmod>2024-04-01</lastmod></url><url><loc>https://td2inc.com/news-events/translational-drug-development-td2-attracts-dallas-partner</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/news-events/td2-expands-clinical-trial-services-into-europe</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2024-09-04</lastmod></url><url><loc>https://td2inc.com/resources/car-t-cell-therapy-revolutionizing-cancer-treatment</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/resources/the-significance-of-preclinical-evaluation-in-car-t-cell-therapy-for-solid-and-hematologic-tumors</loc><image:image><image:loc>https://td2inc.com/hubfs/car-t-blog.jpeg</image:loc><image:caption>car-t-blog</image:caption><image:title>car-t-blog</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/news-events/qualigen-therapeutics-partners-with-td2-for-phase-1-clinical-development-of-qn-302</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/resources/flow-cytometry-evaluation-of-cell-cycle-arrest-in-a549-human-non-small-cell-lung-cancer-cells</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/510.png</image:loc><image:caption>510</image:caption><image:title>510</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2024-06-16</lastmod></url><url><loc>https://td2inc.com/clinical-study-management</loc><image:image><image:loc>https://td2inc.com/hubfs/Webinar%20Hero%20Image.png</image:loc><image:caption>Webinar Hero Image</image:caption><image:title>Webinar Hero Image</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/receptor-mediated-webinar.png</image:loc><image:caption>receptor-mediated-webinar</image:caption><image:title>receptor-mediated-webinar</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/clinical-research-banner-bg.jpg</image:loc><image:caption>clinical-research-banner-bg</image:caption><image:title>clinical-research-banner-bg</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/project-optimus-thumb.jpg</image:loc><image:caption>project-optimus-thumb</image:caption><image:title>project-optimus-thumb</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/icon-Biostatistics.png</image:loc><image:caption>icon-Biostatistics</image:caption><image:title>icon-Biostatistics</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/next-generation-oncology-trials.jpg</image:loc><image:caption>next-generation-oncology-trials</image:caption><image:title>next-generation-oncology-trials</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/icon-Patient-Identification-and-Site-Management.png</image:loc><image:caption>icon-Patient-Identification-and-Site-Management</image:caption><image:title>icon-Patient-Identification-and-Site-Management</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/efficient-data-management.png</image:loc><image:caption>efficient-data-management</image:caption><image:title>efficient-data-management</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/icon-Comprehensive-Site-Management-&amp;-Monitoring.png</image:loc><image:caption>icon-Comprehensive-Site-Management-&amp;-Monitoring</image:caption><image:title>icon-Comprehensive-Site-Management-&amp;-Monitoring</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/icon-Quality-Assurance.png</image:loc><image:caption>icon-Quality-Assurance</image:caption><image:title>icon-Quality-Assurance</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/icon-Medical-Monitoring-Services.png</image:loc><image:caption>icon-Medical-Monitoring-Services</image:caption><image:title>icon-Medical-Monitoring-Services</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/icon-Data-Management.png</image:loc><image:caption>icon-Data-Management</image:caption><image:title>icon-Data-Management</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/icon-Pharmacovigilance.png</image:loc><image:caption>icon-Pharmacovigilance</image:caption><image:title>icon-Pharmacovigilance</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/data-insights.png</image:loc><image:caption>data-insights</image:caption><image:title>data-insights</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/mountain-bg-purple.png</image:loc><image:caption>mountain-bg-purple</image:caption><image:title>mountain-bg-purple</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/icon-Strategic-Third-Party-Vendor-Management.png</image:loc><image:caption>icon-Strategic-Third-Party-Vendor-Management</image:caption><image:title>icon-Strategic-Third-Party-Vendor-Management</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/pd-l1-graphic.png</image:loc><image:caption>pd-l1-graphic</image:caption><image:title>pd-l1-graphic</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/dynamic-trial.png</image:loc><image:caption>dynamic-trial</image:caption><image:title>dynamic-trial</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Oncology-Ecosystem.jpeg</image:loc><image:caption>Oncology-Ecosystem</image:caption><image:title>Oncology-Ecosystem</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/successful-cancer-treatments-trends.png</image:loc><image:caption>successful-cancer-treatments-trends</image:caption><image:title>successful-cancer-treatments-trends</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/icon-eTMF-Management.png</image:loc><image:caption>icon-eTMF-Management</image:caption><image:title>icon-eTMF-Management</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/deep-dive-cro-landscape.png</image:loc><image:caption>deep-dive-cro-landscape</image:caption><image:title>deep-dive-cro-landscape</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/wp-thumb-early-phase.png</image:loc><image:caption>wp-thumb-early-phase</image:caption><image:title>wp-thumb-early-phase</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/icon-Clinical-Flow-Cytometry.png</image:loc><image:caption>icon-Clinical-Flow-Cytometry</image:caption><image:title>icon-Clinical-Flow-Cytometry</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/dive-bg-1.png</image:loc><image:caption>dive-bg-1</image:caption><image:title>dive-bg-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-podcast-biomarkers-and-the-utility-of-proteomics.jpeg</image:loc><image:caption>thumb-podcast-biomarkers-and-the-utility-of-proteomics</image:caption><image:title>thumb-podcast-biomarkers-and-the-utility-of-proteomics</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/cancer-trial-recruitment.png</image:loc><image:caption>cancer-trial-recruitment</image:caption><image:title>cancer-trial-recruitment</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/clinical-trial-img.png</image:loc><image:caption>clinical-trial-img</image:caption><image:title>clinical-trial-img</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/quick-start-guide.png</image:loc><image:caption>quick-start-guide</image:caption><image:title>quick-start-guide</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/clinical-trial-perfromance-metrics.png</image:loc><image:caption>clinical-trial-perfromance-metrics</image:caption><image:title>clinical-trial-perfromance-metrics</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/icon-Study-Design-&amp;-Protocol-Development.png</image:loc><image:caption>icon-Study-Design-&amp;-Protocol-Development</image:caption><image:title>icon-Study-Design-&amp;-Protocol-Development</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2025-06-18</lastmod></url><url><loc>https://td2inc.com/resources/diet-induced-obesity-tumor-models-for-cancer-studies</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/systemic-metabolism.jpg</image:loc><image:caption>systemic-metabolism</image:caption><image:title>systemic-metabolism</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2024-03-31</lastmod></url><url><loc>https://td2inc.com/news-events/what-is-a-randomized-cancer-clinical-trial</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/careers</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-careers.jpg</image:loc><image:caption>og-careers</image:caption><image:title>og-careers</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-comment.png</image:loc><image:caption>icon-comment</image:caption><image:title>icon-comment</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/banner-image.png</image:loc><image:caption>banner-image</image:caption><image:title>banner-image</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2024-04-04</lastmod></url><url><loc>https://td2inc.com/news-events/tara-franks-2023-phoenix-titan-100</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/tara-franks-coo.jpeg</image:loc><image:caption>tara-franks-coo</image:caption><image:title>tara-franks-coo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/pdx-models</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/available-models.png</image:loc><image:caption>available-models</image:caption><image:title>available-models</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/fig3-fig4-charts.png</image:loc><image:caption>fig3-fig4-charts</image:caption><image:title>fig3-fig4-charts</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-clinical-study-management.jpg</image:loc><image:caption>og-clinical-study-management</image:caption><image:title>og-clinical-study-management</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-pk-adme-arrow-down-1.png</image:loc><image:caption>icon-pk-adme-arrow-down-1</image:caption><image:title>icon-pk-adme-arrow-down-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/humanized-pdx-for-oncology-research.png</image:loc><image:caption>humanized-pdx-for-oncology-research</image:caption><image:title>humanized-pdx-for-oncology-research</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-clinical-study-management.png</image:loc><image:caption>icon-clinical-study-management</image:caption><image:title>icon-clinical-study-management</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/pdx-models-flow-chart.png</image:loc><image:caption>pdx-models-flow-chart</image:caption><image:title>pdx-models-flow-chart</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-pk-adme2.png</image:loc><image:caption>icon-pk-adme2</image:caption><image:title>icon-pk-adme2</image:title></image:image><lastmod>2024-12-18</lastmod></url><url><loc>https://td2inc.com/news-events/first-in-human-thunder-god-vine-trial-minnelide</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/news-events/td2-and-navigating-cancer-partner-to-bring-patient-reported-outcomes-to-clinical-trials-through-a-cutting-edge-mobile-application</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/resources/td2-clinical-capabilities</loc><image:image><image:loc>https://td2inc.com/hubfs/thumb-td2-clinical-capabilities.jpeg</image:loc><image:caption>thumb-td2-clinical-capabilities</image:caption><image:title>thumb-td2-clinical-capabilities</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/news-events/td2-supports-the-side-out-foundation-in-clinical-trial-exploring-the-treatment-of-metastatic-breast-cancers-based-on-multi-omic-profiling</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/quality-assurance-services</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-clinical-study-management.jpg</image:loc><image:caption>og-clinical-study-management</image:caption><image:title>og-clinical-study-management</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-clinical-study-management.png</image:loc><image:caption>icon-clinical-study-management</image:caption><image:title>icon-clinical-study-management</image:title></image:image><lastmod>2025-06-18</lastmod></url><url><loc>https://td2inc.com/resources/partner-with-an-experienced-scientifically-driven-cncology-cro</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-partner-with-experienced.jpeg</image:loc><image:caption>thumb-partner-with-experienced</image:caption><image:title>thumb-partner-with-experienced</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/resources/climbing-the-mountain-current-challenges-in-early-phase-oncology-clinical-trials</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/mountain.jpg</image:loc><image:caption>mountain</image:caption><image:title>mountain</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/resources/optimizing-specimen-stability-a-comparative-analysis-of-shipping-protocols</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/white-paper-optimizing-specimen-stability-thumb.png</image:loc><image:caption>white-paper-optimizing-specimen-stability-thumb</image:caption><image:title>white-paper-optimizing-specimen-stability-thumb</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2025-01-06</lastmod></url><url><loc>https://td2inc.com/resources/a-dual-specific-inhibitor-of-rock-aurk-rr-1752-for-primary-myelofibrosis</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/ash-poster-thumb-2.png</image:loc><image:caption>ash-poster-thumb-2</image:caption><image:title>ash-poster-thumb-2</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/small-molecule-cancer-drug-development-services</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-in-vivo.png</image:loc><image:caption>icon-in-vivo</image:caption><image:title>icon-in-vivo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-in-vitro.png</image:loc><image:caption>icon-in-vitro</image:caption><image:title>icon-in-vitro</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-clinical-study-management.png</image:loc><image:caption>icon-clinical-study-management</image:caption><image:title>icon-clinical-study-management</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/small-molecule-cancer-drug-development-services.png</image:loc><image:caption>small-molecule-cancer-drug-development-services</image:caption><image:title>small-molecule-cancer-drug-development-services</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/charts-small-molecules-lg.png</image:loc><image:caption>charts-small-molecules-lg</image:caption><image:title>charts-small-molecules-lg</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/strategic-cnsulting.png</image:loc><image:caption>strategic-cnsulting</image:caption><image:title>strategic-cnsulting</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2025-04-01</lastmod></url><url><loc>https://td2inc.com/news-events/td2-to-highlight-development-of-a-dual-specific-inhibitor-for-treatment-of-primary-myelofibrosis</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><lastmod>2024-02-11</lastmod></url><url><loc>https://td2inc.com/resources/flow-cytometry-application-in-water-microbiology</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/flow-thumb-8.png</image:loc><image:caption>flow-thumb-8</image:caption><image:title>flow-thumb-8</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/news-events/td2-selected-to-conduct-io-preclinical-program-for-atossa-genetics</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/resources/improving-cancer-trial-recruitment-with-advanced-analytics-and-prospective-dataimproving-cancer-trial-recruitment-with-advanced-analytics-and-prospective-data</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/cancer-trial-recruitment.png</image:loc><image:caption>cancer-trial-recruitment</image:caption><image:title>cancer-trial-recruitment</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/news-events/advancing-antibody-drug-conjugate-therapies</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2024-10-15</lastmod></url><url><loc>https://td2inc.com/news-events/nuvilex-selects-translational-drug-development-td2-to-advance-treatment-for-pancreatic-cancer</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/resources/ampd-1-effects-in-dio-and-cd-mice-serum</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/report-thumb.jpeg</image:loc><image:caption>report-thumb</image:caption><image:title>report-thumb</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/resources/technology-and-next-generation-oncology-trials</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/next-generation-oncology-trials.jpg</image:loc><image:caption>next-generation-oncology-trials</image:caption><image:title>next-generation-oncology-trials</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/resources/the-antitumor-and-metabolomic-difference-between-male-and-female-diet-induced-obese-mice-treated-with-check-point-inhibitors</loc><image:image><image:loc>https://td2inc.com/hubfs/1364-thumb.png</image:loc><image:caption>1364-thumb</image:caption><image:title>1364-thumb</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2024-11-19</lastmod></url><url><loc>https://td2inc.com/biostatistics</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-clinical-study-management.jpg</image:loc><image:caption>og-clinical-study-management</image:caption><image:title>og-clinical-study-management</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-clinical-study-management.png</image:loc><image:caption>icon-clinical-study-management</image:caption><image:title>icon-clinical-study-management</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/biostatistics.png</image:loc><image:caption>biostatistics</image:caption><image:title>biostatistics</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2025-06-18</lastmod></url><url><loc>https://td2inc.com/gvhd-mouse-models</loc><image:image><image:loc>https://td2inc.com/hubfs/cgvhd-mouse-models-development.png</image:loc><image:caption>cgvhd-mouse-models-development</image:caption><image:title>cgvhd-mouse-models-development</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-clinical-study-management.jpg</image:loc><image:caption>og-clinical-study-management</image:caption><image:title>og-clinical-study-management</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-clinical-study-management.png</image:loc><image:caption>icon-clinical-study-management</image:caption><image:title>icon-clinical-study-management</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/cgvhd-tbi-chart2.png</image:loc><image:caption>cgvhd-tbi-chart2</image:caption><image:title>cgvhd-tbi-chart2</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/cgvhd-tbi-chart1.png</image:loc><image:caption>cgvhd-tbi-chart1</image:caption><image:title>cgvhd-tbi-chart1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/gvhd-scleroderma-chart2.png</image:loc><image:caption>gvhd-scleroderma-chart2</image:caption><image:title>gvhd-scleroderma-chart2</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/gvhd-scleroderma-chart1.png</image:loc><image:caption>gvhd-scleroderma-chart1</image:caption><image:title>gvhd-scleroderma-chart1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2025-01-16</lastmod></url><url><loc>https://td2inc.com/news-events/pm360-covid-19s-long-lasting-impact-on-clinical-trials</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/news-events/sellas-life-sciences</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/news-events/what-is-standard-therapy-in-cancer-treatment</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/about-td2</loc><image:image><image:loc>https://td2inc.com/hubfs/about-td2.jpg</image:loc><image:caption>about-td2</image:caption><image:title>about-td2</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-about.jpg</image:loc><image:caption>og-about</image:caption><image:title>og-about</image:title></image:image><lastmod>2025-04-08</lastmod></url><url><loc>https://td2inc.com/news-events/td2-oncology-announces-bill-donovan-as-svp-strategic-solutions-to-advance-resourcing-and-fsp-capabilities</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2025-02-11</lastmod></url><url><loc>https://td2inc.com/resources/selective-hdac6-inhibition-by-gb-1101</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/selective-hdac6-inhibition.jpeg</image:loc><image:caption>selective-hdac6-inhibition</image:caption><image:title>selective-hdac6-inhibition</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/resources/orthotopic-vs.-subcutaneous-unpacking-the-strengths-and-limitations-of-tumor-model-implantation-sites</loc><image:image><image:loc>https://td2inc.com/hubfs/vs-mice.png</image:loc><image:caption>vs-mice</image:caption><image:title>vs-mice</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2024-03-26</lastmod></url><url><loc>https://td2inc.com/news-events/td2-and-deep-lens-partner-to-enable-diversity-access-and-faster-clinical-trial-enrollment-for-community-oncology-practices</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/news-events/td2-announces-publication-of-phase-ii-ketogenic-diet-trial-showing-improved-survival-in-metastatic-pancreatic-cancer</loc><image:image><image:loc>https://td2inc.com/hubfs/overall-survival-chart.png</image:loc><image:caption>overall-survival-chart</image:caption><image:title>overall-survival-chart</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2026-03-19</lastmod></url><url><loc>https://td2inc.com/news-events/cytrx-initiates-phase-2-clinical-trial-with-inno-206-in-pancreatic-cancer</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><lastmod>2024-04-01</lastmod></url><url><loc>https://td2inc.com/news-events/scrs-welcomes-td2-as-global-impact-and-oncology-spirit-partner</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2024-06-16</lastmod></url><url><loc>https://td2inc.com/news-events/where-do-cancer-clinical-trials-take-place</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/peak-partners</loc><image:image><image:loc>https://td2inc.com/hubfs/radiopharmaceutical-development.jpg</image:loc><image:caption>radiopharmaceutical-development</image:caption><image:title>radiopharmaceutical-development</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-pk-adme2.png</image:loc><image:caption>icon-pk-adme2</image:caption><image:title>icon-pk-adme2</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/benefits.png</image:loc><image:caption>benefits</image:caption><image:title>benefits</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/radiopharmaceuticals.jpg</image:loc><image:caption>radiopharmaceuticals</image:caption><image:title>radiopharmaceuticals</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/mountain.png</image:loc><image:caption>mountain</image:caption><image:title>mountain</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-pk-adme-arrow-down-1.png</image:loc><image:caption>icon-pk-adme-arrow-down-1</image:caption><image:title>icon-pk-adme-arrow-down-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/peak-partners-seal.png</image:loc><image:caption>peak-partners-seal</image:caption><image:title>peak-partners-seal</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-clinical-study-management.png</image:loc><image:caption>icon-clinical-study-management</image:caption><image:title>icon-clinical-study-management</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2026-04-10</lastmod></url><url><loc>https://td2inc.com/resources/genetically-engineered-humanized-mouse-models</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-pk-adme.jpg</image:loc><image:caption>og-pk-adme</image:caption><image:title>og-pk-adme</image:title></image:image><lastmod>2024-03-31</lastmod></url><url><loc>https://td2inc.com/resources/the-importance-of-metabolic-and-proteomic-analyses-in-identifying-treatment-pathways-for-cancer-patients</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/podcast-thumb.png</image:loc><image:caption>podcast-thumb</image:caption><image:title>podcast-thumb</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/resources/5-ways-dio-mice-enhance-immuno-oncology-discoveries</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/dio-for-io-studies.png</image:loc><image:caption>dio-for-io-studies</image:caption><image:title>dio-for-io-studies</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2024-03-31</lastmod></url><url><loc>https://td2inc.com/pk-adme</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-pk-adme.jpg</image:loc><image:caption>og-pk-adme</image:caption><image:title>og-pk-adme</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-clinical-study-management.png</image:loc><image:caption>icon-clinical-study-management</image:caption><image:title>icon-clinical-study-management</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/biomarkers.png</image:loc><image:caption>biomarkers</image:caption><image:title>biomarkers</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/pkadme-photo.png</image:loc><image:caption>pkadme-photo</image:caption><image:title>pkadme-photo</image:title></image:image><lastmod>2024-03-25</lastmod></url><url><loc>https://td2inc.com/news-events/td2-and-deep-6-ai-announce-partnership-to-accelerate-oncology-clinical-trial-recruitment</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/news-events/td2-is-the-development-partner-for-the-forma-celgene-partnership</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2024-04-01</lastmod></url><url><loc>https://td2inc.com/resources/flow-cytometry-processing-and-analysis-of-tumor-specimens-testing-viability-and-staining-post-shipping</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/flow-thumb-7.png</image:loc><image:caption>flow-thumb-7</image:caption><image:title>flow-thumb-7</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/news-events/asco</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2026-02-20</lastmod></url><url><loc>https://td2inc.com/resources/inhibition-of-hdac3-induces-brcaness-and-potent-synergy</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/inhibition-of-hdac3.jpeg</image:loc><image:caption>inhibition-of-hdac3</image:caption><image:title>inhibition-of-hdac3</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/news-events/nci-and-investigational-drugs-what-is-the-role</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/resources/webinar-fih-clinical-trial-planning-for-radiopharmaceuticals-from-ind-to-patient-dosing</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Webinar%20Hero%20Image.png</image:loc><image:caption>Webinar Hero Image</image:caption><image:title>Webinar Hero Image</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2025-07-29</lastmod></url><url><loc>https://td2inc.com/resources/flow-cytometry-based-receptor-occupancy-assays</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/flow-wp-thumb.png</image:loc><image:caption>flow-wp-thumb</image:caption><image:title>flow-wp-thumb</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2024-08-06</lastmod></url><url><loc>https://td2inc.com/resources/many-drugs-dont-move-past-phase-i-will-yours</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/past-phase-1.png</image:loc><image:caption>past-phase-1</image:caption><image:title>past-phase-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/resources/the-trends-behind-successful-cancer-treatments</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/successful-cancer-treatments-trends.png</image:loc><image:caption>successful-cancer-treatments-trends</image:caption><image:title>successful-cancer-treatments-trends</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/news-events/oral-formulation-of-minnelide-is-dosed-for-the-first-time-in-patients-with-advanced-cancer</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/news-events/flagship-biosciences-finds-arizona-a-great-home-for-serving-pathology-digitally</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2024-04-01</lastmod></url><url><loc>https://td2inc.com/resources/the-dynamic-trial-design</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-the-dynamic-trial-design.jpeg</image:loc><image:caption>thumb-the-dynamic-trial-design</image:caption><image:title>thumb-the-dynamic-trial-design</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/news-events/paradigm-and-td2-announce-strategic-partnership-for-tumor-profiling-service</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/resources/avoiding-delays-in-early-phase-oncology-clinical-trials</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-susan-tessman.jpeg</image:loc><image:caption>thumb-susan-tessman</image:caption><image:title>thumb-susan-tessman</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/news-events/td2-supports-crispr-therapeutics-for-solid-cancer-study-involving-car-t-cells</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/resources/navigating-the-regulatory-process-to-accelerate-drug-development</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-regulatory-process-ebook.png</image:loc><image:caption>thumb-regulatory-process-ebook</image:caption><image:title>thumb-regulatory-process-ebook</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/news-events/td2-works-closely-with-ziopharm-oncology-to-conduct-a-preclinical-study-being-presented-at-the-upcoming-asgct-meeting-in-washington-dc</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/news-events/your-guide-to-a-smart-clinical-strategy</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/resources/the-quick-start-guide-to-clinical-strategy</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/quick-start-guide.png</image:loc><image:caption>quick-start-guide</image:caption><image:title>quick-start-guide</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/comprehensive-site-management-and-monitoring</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-clinical-study-management.png</image:loc><image:caption>icon-clinical-study-management</image:caption><image:title>icon-clinical-study-management</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2025-06-18</lastmod></url><url><loc>https://td2inc.com/news-events/finding-and-selecting-the-right-tumor-models</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/news-events/are-there-other-ways-to-get-investigational-drugs</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/news-events/applied-clinical-trials-when-is-it-time-to-kill-your-drug</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/resources/ebook-using-the-diet-induced-obese-mouse-model-for-modern-cancer-research</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thubm-ebook-cover.jpeg</image:loc><image:caption>thubm-ebook-cover</image:caption><image:title>thubm-ebook-cover</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/news-events/what-is-an-investigational-drug</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/news-events/inform-genomics-and-translational-drug-development-td2-announce-strategic-collaboration</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/comprehensive-clinical-trial-services-for-hematologic-malignancies</loc><image:image><image:loc>https://td2inc.com/hubfs/Hematologic.jpg</image:loc><image:caption>Hematologic</image:caption><image:title>Hematologic</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-pk-adme2.png</image:loc><image:caption>icon-pk-adme2</image:caption><image:title>icon-pk-adme2</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/leveragin-flow-cytometry.png</image:loc><image:caption>leveragin-flow-cytometry</image:caption><image:title>leveragin-flow-cytometry</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/image-bg1.png</image:loc><image:caption>image-bg1</image:caption><image:title>image-bg1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-pk-adme-arrow-down-1.png</image:loc><image:caption>icon-pk-adme-arrow-down-1</image:caption><image:title>icon-pk-adme-arrow-down-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/alan-miller-circle-1.png</image:loc><image:caption>alan-miller-circle-1</image:caption><image:title>alan-miller-circle-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/hematology-oncology-experience-charts-1.png</image:loc><image:caption>hematology-oncology-experience-charts-1</image:caption><image:title>hematology-oncology-experience-charts-1</image:title></image:image><lastmod>2025-07-16</lastmod></url><url><loc>https://td2inc.com/regulatory-support-old</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-medical-writing.png</image:loc><image:caption>icon-medical-writing</image:caption><image:title>icon-medical-writing</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/strategic-cnsulting.png</image:loc><image:caption>strategic-cnsulting</image:caption><image:title>strategic-cnsulting</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-pk-adme-arrow-down-1.png</image:loc><image:caption>icon-pk-adme-arrow-down-1</image:caption><image:title>icon-pk-adme-arrow-down-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-the-dynamic-trial-design.jpeg</image:loc><image:caption>thumb-the-dynamic-trial-design</image:caption><image:title>thumb-the-dynamic-trial-design</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-clinical-study-management.png</image:loc><image:caption>icon-clinical-study-management</image:caption><image:title>icon-clinical-study-management</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/regsup-img2.png</image:loc><image:caption>regsup-img2</image:caption><image:title>regsup-img2</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-regulatory-process-ebook.png</image:loc><image:caption>thumb-regulatory-process-ebook</image:caption><image:title>thumb-regulatory-process-ebook</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/regsup-img1.png</image:loc><image:caption>regsup-img1</image:caption><image:title>regsup-img1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-regulatory-support.jpg</image:loc><image:caption>og-regulatory-support</image:caption><image:title>og-regulatory-support</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-pk-adme2.png</image:loc><image:caption>icon-pk-adme2</image:caption><image:title>icon-pk-adme2</image:title></image:image><lastmod>2025-02-04</lastmod></url><url><loc>https://td2inc.com/news-events/rct-acquires-translational-drug-development-llc</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/resources/selective-hdac6-inhibition</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/thumb-poster-selective-hdac6-inhibition.jpg</image:loc><image:caption>thumb-poster-selective-hdac6-inhibition</image:caption><image:title>thumb-poster-selective-hdac6-inhibition</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/resources/executive-interview-with-td2</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-executive-interview-with-td2.jpeg</image:loc><image:caption>thumb-executive-interview-with-td2</image:caption><image:title>thumb-executive-interview-with-td2</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/resources/leading-the-way-in-defining-a-new-irs-to-predict-checkpoint-inhibitor-benefit</loc><image:image><image:loc>https://td2inc.com/hubfs/pd-l1-graphic.png</image:loc><image:caption>pd-l1-graphic</image:caption><image:title>pd-l1-graphic</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/clinical-trial-services-for-antibody-drug-conjugates</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-clinical-study-management.png</image:loc><image:caption>icon-clinical-study-management</image:caption><image:title>icon-clinical-study-management</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-pk-adme-arrow-down-1.png</image:loc><image:caption>icon-pk-adme-arrow-down-1</image:caption><image:title>icon-pk-adme-arrow-down-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/translating-preclinical-adc-insights-into-clinical-success.png</image:loc><image:caption>translating-preclinical-adc-insights-into-clinical-success</image:caption><image:title>translating-preclinical-adc-insights-into-clinical-success</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-pk-adme2.png</image:loc><image:caption>icon-pk-adme2</image:caption><image:title>icon-pk-adme2</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/adcs-in-cancer-treatment.png</image:loc><image:caption>adcs-in-cancer-treatment</image:caption><image:title>adcs-in-cancer-treatment</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/adc.jpg</image:loc><image:caption>adc</image:caption><image:title>adc</image:title></image:image><lastmod>2025-06-18</lastmod></url><url><loc>https://td2inc.com/news-events</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><lastmod>2024-06-11</lastmod></url><url><loc>https://td2inc.com/resources/clinical-trial-highlight</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-clinical-trial-highlight.jpeg</image:loc><image:caption>thumb-clinical-trial-highlight</image:caption><image:title>thumb-clinical-trial-highlight</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/resources/early-phase-oncology-trial-designs-phase-i-strategies-tailored-for-success</loc><image:image><image:loc>https://td2inc.com/hubfs/wp-thumb-early-phase.png</image:loc><image:caption>wp-thumb-early-phase</image:caption><image:title>wp-thumb-early-phase</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/news-events/td2-supports-the-successful-ind-filing-for-genzada-pharmaceuticals</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/resources/6-signs-you-need-a-new-cro-for-your-preclinical-research</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/6-signs.png</image:loc><image:caption>6-signs</image:caption><image:title>6-signs</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/news-events/td2-oncology-and-curadh-enter-strategic-collaboration-to-advance-radiopharmaceutical-clinical-trials</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2025-07-29</lastmod></url><url><loc>https://td2inc.com/news-events/laidlaw-venture-partners-portfolio-company-voltron-therapeutics-enters-into-strategic-development-agreement</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/privacy-policy</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-home.jpg</image:loc><image:caption>og-home</image:caption><image:title>og-home</image:title></image:image><lastmod>2024-02-18</lastmod></url><url><loc>https://td2inc.com/news-events/mpi-and-td2-join-in-strategic-collaboration-to-provide-drug-developers-a-unique-multi-biomarker-direct-path-to-drug-approval</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/news-events/genzada-pharmaceuticals-doses-first-patient</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/news-events/6-signs-you-need-a-new-cro-for-your-preclinical-research</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/clinical-trial-services-for-small-molecules</loc><image:image><image:loc>https://td2inc.com/hubfs/small-molecules.jpg</image:loc><image:caption>small-molecules</image:caption><image:title>small-molecules</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-pk-adme-arrow-down-1.png</image:loc><image:caption>icon-pk-adme-arrow-down-1</image:caption><image:title>icon-pk-adme-arrow-down-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/charts-small-molecules-lg.png</image:loc><image:caption>charts-small-molecules-lg</image:caption><image:title>charts-small-molecules-lg</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/small-molecules.png</image:loc><image:caption>small-molecules</image:caption><image:title>small-molecules</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-clinical-study-management.png</image:loc><image:caption>icon-clinical-study-management</image:caption><image:title>icon-clinical-study-management</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-pk-adme2.png</image:loc><image:caption>icon-pk-adme2</image:caption><image:title>icon-pk-adme2</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2025-06-18</lastmod></url><url><loc>https://td2inc.com/news-events/are-cancer-clinical-trials-just-for-advanced-cancer</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/medical-monitoring-services</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-clinical-study-management.jpg</image:loc><image:caption>og-clinical-study-management</image:caption><image:title>og-clinical-study-management</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-clinical-study-management.png</image:loc><image:caption>icon-clinical-study-management</image:caption><image:title>icon-clinical-study-management</image:title></image:image><lastmod>2025-06-18</lastmod></url><url><loc>https://td2inc.com/resources/ind-readiness</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/shutterstock_267243104.jpg</image:loc><image:caption>shutterstock_267243104</image:caption><image:title>shutterstock_267243104</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2025-02-27</lastmod></url><url><loc>https://td2inc.com/preclinical</loc><image:image><image:loc>https://td2inc.com/hubfs/systemic-metabolism.jpg</image:loc><image:caption>systemic-metabolism</image:caption><image:title>systemic-metabolism</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/6491.png</image:loc><image:caption>6491</image:caption><image:title>6491</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/dio-for-io-studies.png</image:loc><image:caption>dio-for-io-studies</image:caption><image:title>dio-for-io-studies</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/services-catalog-thumb.png</image:loc><image:caption>services-catalog-thumb</image:caption><image:title>services-catalog-thumb</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/selective-hdac6-inhibition.jpeg</image:loc><image:caption>selective-hdac6-inhibition</image:caption><image:title>selective-hdac6-inhibition</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/dive-bg-1.png</image:loc><image:caption>dive-bg-1</image:caption><image:title>dive-bg-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Oncology-Ecosystem.jpeg</image:loc><image:caption>Oncology-Ecosystem</image:caption><image:title>Oncology-Ecosystem</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/vs-mice.png</image:loc><image:caption>vs-mice</image:caption><image:title>vs-mice</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/inhibition-of-hdac3.jpeg</image:loc><image:caption>inhibition-of-hdac3</image:caption><image:title>inhibition-of-hdac3</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/podcast-thumb.png</image:loc><image:caption>podcast-thumb</image:caption><image:title>podcast-thumb</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-the-dynamic-trial-design.jpeg</image:loc><image:caption>thumb-the-dynamic-trial-design</image:caption><image:title>thumb-the-dynamic-trial-design</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/thumb-poster-inhibition-of-hdac3.jpg</image:loc><image:caption>thumb-poster-inhibition-of-hdac3</image:caption><image:title>thumb-poster-inhibition-of-hdac3</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/mountain-bg-purple.png</image:loc><image:caption>mountain-bg-purple</image:caption><image:title>mountain-bg-purple</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/pd-l1-graphic.png</image:loc><image:caption>pd-l1-graphic</image:caption><image:title>pd-l1-graphic</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-pk-adme.jpg</image:loc><image:caption>og-pk-adme</image:caption><image:title>og-pk-adme</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-abstract8.png</image:loc><image:caption>thumb-abstract8</image:caption><image:title>thumb-abstract8</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thubm-ebook-cover.jpeg</image:loc><image:caption>thubm-ebook-cover</image:caption><image:title>thubm-ebook-cover</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/1364-thumb.png</image:loc><image:caption>1364-thumb</image:caption><image:title>1364-thumb</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-checkpoint-inhibitors.jpeg</image:loc><image:caption>thumb-checkpoint-inhibitors</image:caption><image:title>thumb-checkpoint-inhibitors</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/global-metabolomics.png</image:loc><image:caption>global-metabolomics</image:caption><image:title>global-metabolomics</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/thumb-wp-exploring-the-effects-of-microbiome.jpg</image:loc><image:caption>thumb-wp-exploring-the-effects-of-microbiome</image:caption><image:title>thumb-wp-exploring-the-effects-of-microbiome</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-lb343.jpeg</image:loc><image:caption>thumb-lb343</image:caption><image:title>thumb-lb343</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/thumb-poster-selective-hdac6-inhibition.jpg</image:loc><image:caption>thumb-poster-selective-hdac6-inhibition</image:caption><image:title>thumb-poster-selective-hdac6-inhibition</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/report-thumb.jpeg</image:loc><image:caption>report-thumb</image:caption><image:title>report-thumb</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Preclinical-banner2.jpg</image:loc><image:caption>Preclinical-banner2</image:caption><image:title>Preclinical-banner2</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/ash-poster-thumb-2.png</image:loc><image:caption>ash-poster-thumb-2</image:caption><image:title>ash-poster-thumb-2</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/thumb-poc.png</image:loc><image:caption>thumb-poc</image:caption><image:title>thumb-poc</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-webinar-clinical-success.png</image:loc><image:caption>thumb-webinar-clinical-success</image:caption><image:title>thumb-webinar-clinical-success</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/past-phase-1.png</image:loc><image:caption>past-phase-1</image:caption><image:title>past-phase-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/6908.png</image:loc><image:caption>6908</image:caption><image:title>6908</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/6-signs.png</image:loc><image:caption>6-signs</image:caption><image:title>6-signs</image:title></image:image><lastmod>2025-04-07</lastmod></url><url><loc>https://td2inc.com/news-events/td2-to-highlight-preclinical-progress-of-two-novel-hdac-inhibitors-at-aacr-annual-meeting</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/news-events/td2-receives-three-year-renewal-of-aaalac-accreditation</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/resources/measurement-of-cytokine-mrna-expression-by-flow-cytometry-using-the-branched-dna-technology</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/flow-thumb-5.png</image:loc><image:caption>flow-thumb-5</image:caption><image:title>flow-thumb-5</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/news-events/why-are-randomized-cancer-clinical-trials-important-in-developing-new-treatments-for-cancer</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/resources/advancing-preclinical-cancer-research-through-metabolomics</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/global-metabolomics.png</image:loc><image:caption>global-metabolomics</image:caption><image:title>global-metabolomics</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2024-03-31</lastmod></url><url><loc>https://td2inc.com/news-events/tgen-td2-scottsdale-healthcare-breast-cancer-pilot-study</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/resources/model-and-bioanalytical-services-catalog</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/services-catalog-thumb.png</image:loc><image:caption>services-catalog-thumb</image:caption><image:title>services-catalog-thumb</image:title></image:image><lastmod>2024-08-06</lastmod></url><url><loc>https://td2inc.com/old</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-preclinical.png</image:loc><image:caption>icon-preclinical</image:caption><image:title>icon-preclinical</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/banner-image.png</image:loc><image:caption>banner-image</image:caption><image:title>banner-image</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/banner-background-image.jpg</image:loc><image:caption>banner-background-image</image:caption><image:title>banner-background-image</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/section2-img.png</image:loc><image:caption>section2-img</image:caption><image:title>section2-img</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/about-td2-img.png</image:loc><image:caption>about-td2-img</image:caption><image:title>about-td2-img</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-clinical-study-management.png</image:loc><image:caption>icon-clinical-study-management</image:caption><image:title>icon-clinical-study-management</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-regulatory-support.png</image:loc><image:caption>icon-regulatory-support</image:caption><image:title>icon-regulatory-support</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-home.jpg</image:loc><image:caption>og-home</image:caption><image:title>og-home</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/icon-pk-adme.png</image:loc><image:caption>icon-pk-adme</image:caption><image:title>icon-pk-adme</image:title></image:image><lastmod>2024-12-09</lastmod></url><url><loc>https://td2inc.com/news-events/applied-clinical-trials-small-biopharma-and-cros-seeking-stronger-synergies</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/news-events/td2-partners-with-medidata-to-enhance-its-clinical-operations-and-accelerate-clinical-trials</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/resources/td2-immuno-oncology</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-td2-immuno-oncology.jpeg</image:loc><image:caption>thumb-td2-immuno-oncology</image:caption><image:title>thumb-td2-immuno-oncology</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/news-events/td2-expands-preclinical-and-clinical-services-by-acquiring-flow-contract-site-laboratory-fcsl</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2024-06-16</lastmod></url><url><loc>https://td2inc.com/resources/antitumor-and-metabolomic-evaluation-of-immune-checkpoint-inhibition-in-diet-induced-obese-mice</loc><image:image><image:loc>https://td2inc.com/hubfs/thumb-lb343.jpeg</image:loc><image:caption>thumb-lb343</image:caption><image:title>thumb-lb343</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/search-results</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-home.jpg</image:loc><image:caption>og-home</image:caption><image:title>og-home</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2024-03-22</lastmod></url><url><loc>https://td2inc.com/resources/checkpoint-inhibitors-the-gut-microbiomes-role-in-anti-tumor-response</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/thumb-checkpoint-inhibitors.jpeg</image:loc><image:caption>thumb-checkpoint-inhibitors</image:caption><image:title>thumb-checkpoint-inhibitors</image:title></image:image><lastmod>2024-03-21</lastmod></url><url><loc>https://td2inc.com/news-events/td2-announces-dr-alan-miller-as-new-chief-medical-officer</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><lastmod>2024-02-21</lastmod></url><url><loc>https://td2inc.com/resources/early-steps-to-clinical-success</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/video-thumb-stephen-gately.png</image:loc><image:caption>video-thumb-stephen-gately</image:caption><image:title>video-thumb-stephen-gately</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><lastmod>2024-07-17</lastmod></url><url><loc>https://td2inc.com/resources/podcast-steve-gately-joins-bourne-partners-for-a-deep-dive-on-the-future-of-oncology-cros</loc><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/deep-dive-cro-landscape.png</image:loc><image:caption>deep-dive-cro-landscape</image:caption><image:title>deep-dive-cro-landscape</image:title></image:image><lastmod>2025-12-16</lastmod></url><url><loc>https://td2inc.com/news-events/aacr-annual-meeting-2023</loc><image:image><image:loc>https://td2inc.com/hubfs/td2-logo.png</image:loc><image:caption>td2-logo</image:caption><image:title>td2-logo</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png</image:loc><image:caption>search-icon-1</image:caption><image:title>search-icon-1</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Images/og-news-events.jpg</image:loc><image:caption>og-news-events</image:caption><image:title>og-news-events</image:title></image:image><image:image><image:loc>https://td2inc.com/hubfs/Assets/Logo/acclac-logo.png</image:loc><image:caption>acclac-logo</image:caption><image:title>acclac-logo</image:title></image:image><lastmod>2024-02-21</lastmod></url></urlset>